Ro has expanded its partnership with Pfizer. The telehealth startup will now offer generic versions of Pfizer’s blood pressure medicine Lipitor and cholesterol drug Norvasc through its mail-order pharmacy. (STAT)

UnitedHealth Group has acquired start-up DivvyDose for more than $300 million. The company delivers pre-sorted medications to individuals with chronic conditions. DivvyDose competes with PillPack, bought by Amazon in June 2018. (CNBC)

Becton Dickinson’s 15-minute coronavirus test has been approved in Europe. The rapid antigen test is expected to be sold in October to emergency rooms, general practitioners and pediatricians. (Bloomberg)

Hydroxychloroquine does not prevent COVID-19, according to a study from the University of Pennsylvania. Full data will be published in JAMA Internal Medicine. (Reuters)

Today is the final day of the MM+M Transform virtual conference. Join us for panel discussions about transforming the future of health marketing. (MM+M)